id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-2660-0003,FDA,FDA-2015-E-2660,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T15:50:59Z,,0,0,0900006481cd573a
FDA-2015-E-2660-0002,FDA,FDA-2015-E-2660,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T12:14:46Z,,0,0,0900006481ba5783
FDA-2015-E-2660-0001,FDA,FDA-2015-E-2660,"Patent Extension Application from Lathrop & Gage LLP (on behalf of  Emory University, Baxter International Inc., and Baxter Healthcare SA)",Other,Application,2015-07-27T04:00:00Z,2015,7,2015-07-27T04:00:00Z,,2015-07-27T12:14:32Z,,0,0,0900006481ba5785